drugset / Trial / NCT05658887

Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery

NCT05658887

Phase 4 Completed 110 enrolled Joseph Kowalski University of Iowa · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will recruit women scheduled to undergo vaginal apical suspension surgery (either uterosacral ligament suspension or sacrospinous ligament fixation) with or without other prolapse or anti-incontinence procedures. Participants will be randomized 1:1 to preoperative gabapentin or preoperative placebo (both patients and investigators will be blinded). Note the control group will receive preoperative acetaminophen/celecoxib/placebo and the treatment group will receive preoperative acetaminophen/celecoxib/gabapentin (preoperative acetaminophen/celecoxib are part of our current ERAS protocol). The primary outcome will be postoperative opioid use in the first 24 hours postoperatively measured in morphine milligram equivalents.

Timeline

Start
2023-01-01
Primary completion
2024-12-31
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg

Indications